Adipose Tissue Distribution and Survival Among Women with Nonmetastatic Breast Cancer.
Journal
Obesity (Silver Spring, Md.)
ISSN: 1930-739X
Titre abrégé: Obesity (Silver Spring)
Pays: United States
ID NLM: 101264860
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
19
09
2018
accepted:
07
02
2019
pubmed:
26
4
2019
medline:
12
3
2020
entrez:
26
4
2019
Statut:
ppublish
Résumé
Previous studies of breast cancer survival have not considered specific depots of adipose tissue such as subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT). This study assessed these relationships among 3,235 women with stage II and III breast cancer diagnosed between 2005 and 2013 at Kaiser Permanente Northern California and between 2000 and 2012 at Dana Farber Cancer Institute. SAT and VAT areas (in centimeters squared) were calculated from routine computed tomography scans within 6 (median: 1.2) months of diagnosis, covariates were collected from electronic health records, and vital status was assessed by death records. Hazard ratios (HRs) and 95% CIs were estimated using Cox regression. SAT and VAT ranged from 19.0 to 891 cm SAT may be an underappreciated risk factor for breast cancer-related death.
Identifiants
pubmed: 31021535
doi: 10.1002/oby.22458
pmc: PMC6533153
mid: NIHMS1521750
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
997-1004Subventions
Organisme : NCI NIH HHS
ID : R01 CA184953
Pays : United States
Informations de copyright
© 2019 The Obesity Society.
Références
Br J Cancer. 2017 Jun 27;117(1):148-155
pubmed: 28588319
Nature. 2006 Dec 14;444(7121):881-7
pubmed: 17167477
Ann Epidemiol. 1997 Apr;7(3):188-93
pubmed: 9141641
Int J Epidemiol. 2006 Feb;35(1):83-92
pubmed: 16339600
Endocr Rev. 2000 Dec;21(6):697-738
pubmed: 11133069
Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1244-59
pubmed: 22695735
Curr Opin Clin Nutr Metab Care. 2015 Nov;18(6):535-51
pubmed: 26335310
Breast Cancer Res Treat. 2014 Aug;146(3):647-55
pubmed: 25056184
Annu Rev Med. 2015;66:297-309
pubmed: 25587653
Metabolism. 2001 Apr;50(4):425-35
pubmed: 11288037
Am J Clin Nutr. 2013 Mar;97(3):480-6
pubmed: 23364010
J Clin Endocrinol Metab. 2011 Sep;96(9):2898-903
pubmed: 21778224
Cell Metab. 2008 May;7(5):410-20
pubmed: 18460332
Cancer Causes Control. 2015 Dec;26(12):1803-11
pubmed: 26428518
Obesity (Silver Spring). 2010 Jun;18(6):1183-7
pubmed: 19851312
Appl Physiol Nutr Metab. 2008 Oct;33(5):997-1006
pubmed: 18923576
Obes Res. 2002 Apr;10(4):266-9
pubmed: 11943835
Maturitas. 2010 May;66(1):5-15
pubmed: 20097494
Nat Rev Cancer. 2015 Aug;15(8):484-98
pubmed: 26205341
JPEN J Parenter Enteral Nutr. 2014 Nov;38(8):940-53
pubmed: 25239112
Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1871-7
pubmed: 17035393
Eur J Clin Nutr. 2011 Jul;65(7):784-90
pubmed: 21427743
Am J Med. 2006 Jun;119(6):526.e9-17
pubmed: 16750969
Cancer Prev Res (Phila). 2017 Apr;10(4):235-243
pubmed: 28270386
Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1260-71
pubmed: 22695738
Int J Obes (Lond). 2013 Apr;37(4):620-2
pubmed: 22641063
Obes Rev. 2010 Jan;11(1):11-8
pubmed: 19656312
J Appl Physiol (1985). 2004 Dec;97(6):2333-8
pubmed: 15310748
Am J Epidemiol. 2006 Jan 15;163(2):101-7
pubmed: 16339054
Diabetes. 1997 Oct;46(10):1579-85
pubmed: 9313753
Eur J Cancer Care (Engl). 2018 Mar;27(2):e12611
pubmed: 27921375
Cancer Med. 2016 Jan;5(1):41-8
pubmed: 26626021
Int J Obes (Lond). 2010 Dec;34 Suppl 2:S4-17
pubmed: 21151146
Am J Epidemiol. 2003 Nov 15;158(10):963-8
pubmed: 14607804
JAMA Oncol. 2018 Jun 1;4(6):798-804
pubmed: 29621380
Am J Physiol Endocrinol Metab. 2000 May;278(5):E941-8
pubmed: 10780952
Am J Med. 2015 Apr;128(4):334-6
pubmed: 25460531
Ann Oncol. 2014 Oct;25(10):1901-14
pubmed: 24769692